NEOGENOMICS INC - NOTE 0.250% 1/1

Historical Holders from Q1 2021 to Q3 2025

Type / Class
Debt / NOTE 0.250% 1/1
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal, excl. options
345,063,000
Holdings value
$300,247,353
% of all portfolios
0%
Number of holders
21
Number of buys
9
Number of sells
-13
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of NEOGENOMICS INC - NOTE 0.250% 1/1

Period Principal Value Change Price Investors
2025 Q3 345,063,000 $300,247,353 -$1,047,258 $0.865 21
2025 Q2 347,424,500 $298,701,017 +$1,329,076 $0.8538 24
2025 Q1 345,968,500 $300,355,654 +$507,793 $0.8632 24
2024 Q4 346,156,500 $292,693,370 -$7,990,591 $0.84 27
2024 Q3 356,060,500 $296,374,577 +$17,437,220 $0.8286 28
2024 Q2 335,580,500 $263,497,607 +$1,308,070 $0.7817 28
2024 Q1 333,774,500 $266,976,531 +$1,456,937 $0.7975 25
2023 Q4 333,400,500 $253,694,214 +$3,165,777 $0.756 30
2023 Q3 329,987,000 $237,042,492 -$556,393 $0.7153 28
2023 Q2 330,413,000 $243,310,105 -$296,237 $0.7332 32
2023 Q1 330,802,000 $244,199,793 +$1,969,797 $0.7351 30
2022 Q4 331,631,000 $215,226,340 +$776,251 $0.6463 33
2022 Q3 277,556,500 $183,092,769 -$26,084,301 $0.6464 31
2022 Q2 318,858,347 $202,728,341 +$10,098,000 $0.6213 30
2022 Q1 298,643,089 $201,340,104 -$2,525,738 $0.6657 36
2021 Q4 293,181,906 $250,805,827 -$23,948,051 $0.8541 31
2021 Q3 320,195,500 $323,656,284 +$11,107,101 $1.01 33
2021 Q2 308,715,774 $302,787,253 +$10,622,528 $0.9762 29
2021 Q1 298,991,370 $302,575,255 +$302,575,255 $1.01 38